- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Treats Adults
Mehdi S Mirsaeidi, MD, MPH
Pulmonologist, Critical Care Medicine Physician
Mehdi S Mirsaeidi, MD, MPH
- Additional languages:
- Persian
Request appointment online
Research at a glance
Top areas of exploration
- Mycobacterium tuberculosis , 21 publications
- Antitubercular Agents , 20 publications
- COVID-19 , 18 publications
- Tuberculosis, Pulmonary , 15 publications
Research activity
Active clinical trials
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 30 Years - NA Years
- Sexes
- All
- Investigator
- Mehdi S Mirsaeidi
- Status
- Accepting Candidates
- Ages
- 18 Years - 85 Years
- Sexes
- All
My publications
Filter publications
241 publications
2017
Recurrent Drug-Induced Hepatitis in Tuberculosis-Comparison of Two Drug Regimens.
American journal of therapeutics
鈥�2017
Cardiovascular complications and mortality determinants in near drowning victims: A 5-year retrospective analysis.
Journal of critical care
鈥�2016
Annexin A11 is associated with pulmonary fibrosis in African American patients with sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
2016
The association between BNP, 6MWD test, DLCO% and pulmonary hypertension in sarcoidosis.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG
2016
Duration of ECMO Is an Independent Predictor of Intracranial Hemorrhage Occurring During ECMO Support.
ASAIO journal (American Society for Artificial Internal Organs : 1992)
鈥�